| Literature DB >> 33515162 |
Gayathri S Kumar1, Jenna A Beeler2, Emma E Seagle2, Emily S Jentes2.
Abstract
Several studies describe the health of recently resettled refugee populations in the US beyond the first 8 months after arrival. This review summarizes the results of these studies. Scientific articles from five databases published from January 2008 to March 2019 were reviewed. Articles were included if study subjects included any of the top five US resettlement populations during 2008-2018 and if data described long-term physical health outcomes beyond the first 8 months after arrival in the US. Thirty-three studies met the inclusion criteria (1.5%). Refugee adults had higher odds of having a chronic disease compared with non-refugee immigrant adults, and an increased risk for diabetes compared with US-born controls. The most commonly reported chronic diseases among Iraqi, Somali, and Bhutanese refugee adults included diabetes and hypertension. Clinicians should consider screening and evaluating for chronic conditions in the early resettlement period. Further evaluations can build a more comprehensive, long-term health profile of resettled refugees to inform public health practice.Entities:
Keywords: Chronic disease; Non-communicable disease; Physical health; Refugees
Year: 2021 PMID: 33515162 PMCID: PMC8233239 DOI: 10.1007/s10903-021-01146-2
Source DB: PubMed Journal: J Immigr Minor Health ISSN: 1557-1912
Fig. 1Flow of identification, screening, and review of articles during the literature review
Summary of primary findings of review of longer-term physical health outcomes among resettled refugee adults in the United Statesa
| Refugee population | No. of studies | Sample size | Summary of primary findings | Comparison group(s) |
|---|---|---|---|---|
| Chronic conditions | 2 | 480–549 (refugees) 3715–7654 (non-refugee immigrants) | Higher prevalence of having a chronic condition compared to non-refugee immigrants (21–25% vs. 13–16%) [ Greater odds of having a chronic condition compared to non-refugee immigrants (OR: 1.9 [95%CI 1.4–2.5]) [ | Non-refugee immigrants [ |
| Diabetes | 4 | 478–3174 (refugees) 3715–7654 (non-refugee immigrants) | Prevalence of diabetes ranged from 5–6% [ Increased risk of diabetes compared to US-born controls (HR: 2.1; 95% CI 1.3–3.3) [ Estimated 12% odds of developing diabetes for each year post-resettlement to the US (OR: 1.12; 95% CI 1.0–1.2) [ | Non-refugee immigrants [ |
| Hypertension | 3 | 480–559 (refugees) 3715–7654 (non-refugee immigrants) | Prevalence of hypertension ranged from 12–14% [ Estimated 7% odds of developing hypertension for each year post-resettlement to the US (OR 1.07; 95% CI 1.0–1.1) [ | Non-refugee immigrants [ |
| Vitamin D deficiency | 1 | 1378 | Higher prevalence of Vitamin D deficiency compared to US-born population (60% vs. 35%) [ Greater odds of Vitamin D deficiency (OR: 3.0; 95% CI 2.1–4.4) [ | US-born population [ |
| Diabetes | 2 | 220–260 | Prevalence of diabetes ranged from 9–17% [ | |
| Dyslipidemia | 2 | 133–260 (refugees) 133 (non-refugees) | Prevalence of elevated cholesterol ranged from 8–18% [ Lower prevalence of hyperlipidemia compared to non-refugees (8% vs. 12%) [ | Non-refugees [ |
| Hypertension | 2 | 133 (refugees) 133 (non-refugees) | Lower prevalence of hypertension compared to non-refugees (19% vs. 35%) [ | Non-refugees [ |
| Obesity/overweight | 1 | 133 (refugees) 133 (non-refugees) | Prevalence of obesity was 27% [ Lower prevalence of obesity compared to non-refugees (27% vs. 41%) [ | Non-refugees [ |
| Diabetes | 3 | 66–120 | Prevalence of diabetes ranged from 6–14% [ | – |
| Hypertension | 3 | 66–120 | Prevalence of hypertension ranged from 19–27% [ | – |
| Overweight/obesity | 4 | 66–120 | Prevalence of overweight/obesity ranged from 4–52% [ | – |
| Vitamin B12 deficiency | 2 | 66–141 | Prevalence of Vitamin B deficiency ranged from 12–32% [ | – |
| Prediabetes/diabetes | 2 | 72–1007 (Somali) 1010 (non-Somali) | Higher prevalence of prediabetes compared to non-Somali patients (21% vs. 17%) [ Greater odds of prediabetes (OR: 1.6; 95% CI 1.2–2.1) [ Prevalence of diabetes ranged from 12–24% [ Greater odds of diabetes (OR: 2.8; 95% CI 1.8–4.4) [ | Non-Somali patients [ |
| Hypertension | 2 | 72–1007 (Somali) | Prevalence of hypertension ranged from 17–32% [ | |
| Overweight/obesity | 2 | 72–1007 (Somali) 1010 (non-Somali) | Prevalence of obesity ranged from 35–41% [ | Non-Somali patients [ |
| Chronic conditions | 2 | 366 | Prevalence of ≥ 1 chronic condition was 60% [ | – |
| Diabetes | 2 | 290–366 | Prevalence of diabetes ranged from 6–16% [ | – |
| Hypertension | 3 | 290–366 | Prevalence of hypertension ranged from 13–35% [ | – |
| Overweight/obesity | 2 | 290 | Prevalence of overweight and obesity was 38% [ Prevalence of obesity was 22% [ Greater increase in BMI among females (1.4 kg/m2) compared to males (0.4 kg/m2) [ | – |
OR odds ratio, CI confidence interval, BMI body-mass-index (kg/m2)
aIncludes top 5 resettled refugee populations by volume in the United States: Burmese, Iraqi, Bhutanese, Somali, and Congolese. Not all findings from studies are included in the table
bNon-refugee immigrants in these studies denote individuals who received legal permanent residency in the United States, but not via refugee visa. Individuals were categorized based on their pre-LPR visa category, which included temporary students, workers or visitors; undocumented immigrants; or immigrant spouses, fiancés, or children of US citizens or LPRs
Summary of primary findings of review of longer-term physical health outcomes among resettled refugee children in the United Statesa
| Refugee population | No. of studies | Sample size | Summary of primary findings |
|---|---|---|---|
| Overweight/obesity | 4 | 181–1067 | Baseline prevalence of overweight and obesity ranged from 9–17% and increased to 21–35% several years post-resettlement [ |
| Acute/chronic malnutrition | 2 | 199–512 | Prevalence of acute and chronic malnutrition were not different from time of first measurement (acute malnutrition: 5%; chronic malnutrition: 9%) to time of last measurement [ Average height-for-age z scores increased from time of initial assessment over the next five years (baseline range: − 1.36 to − 1.13; five years: − 0.79) [ |
| Elevated blood lead levels (EBLL) | 2 | 199–1726 | Prevalence of EBLL ranged between 6–11% [ |
| Vitamin D deficiency | 1 | 199–225 | Prevalence of Vitamin D deficiency was 87% [ |
| Anemia | 2 | 198–225 | Prevalence of anemia was 25% [ |
| Tuberculosis | 2 | 198–225 | Prevalence of latent tuberculosis was 61% [ Prevalence of a positive PPD result ranged from 15 to 23% [ |
| EBLL | 1 | 197 | Prevalence of EBLL > 5 mcg/dL was 37% [ Prevalence of EBLL > 10 mcg/dL was 7% [ |
EBLL elevated blood lead level
aIncludes top 5 resettled refugee populations by volume in the United States: Burmese, Iraqi, Bhutanese, Somali, and Congolese. Not all findings from studies are included in the table